India, Nov. 28 -- SMPL

New Delhi [India], November 28: CliniExperts Research Services Pvt. Ltd., New Delhi, India proudly announces the successful completion of Phase IV study on Akynzeo(R) I.V for Glenmark Pharmaceuticals ltd. As a CRO, CliniExperts provided end to end Clinical Support including Site Management and Clinical Operations support.

Study Title: An open label, single arm, multicenter, prospective study to evaluate safety and effectiveness of Akynzeo(R) I.V. [Fosnetupitant 235 mg and Palonosetron 0.25 mg (concentrate for solution for infusion)], in the Prevention of chemotherapy induced nausea and vomiting (CINV) in Indian patients (STOP-CINV study).

Study Design:

- 178 adult patients (male or female) aged >=18 and <=75 yea...